ArticleExperimental and therapeutic medicine2015

Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells.

Qingwei Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.